Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 218

1.

Strategy of Human Cytomegalovirus To Escape Interferon Beta-Induced APOBEC3G Editing Activity.

Pautasso S, Galitska G, Dell'Oste V, Biolatti M, Cagliani R, Forni D, De Andrea M, Gariglio M, Sironi M, Landolfo S.

J Virol. 2018 Sep 12;92(19). pii: e01224-18. doi: 10.1128/JVI.01224-18. Print 2018 Oct 1.

2.

APOBEC3A Is Upregulated by Human Cytomegalovirus (HCMV) in the Maternal-Fetal Interface, Acting as an Innate Anti-HCMV Effector.

Weisblum Y, Oiknine-Djian E, Zakay-Rones Z, Vorontsov O, Haimov-Kochman R, Nevo Y, Stockheim D, Yagel S, Panet A, Wolf DG.

J Virol. 2017 Nov 14;91(23). pii: e01296-17. doi: 10.1128/JVI.01296-17. Print 2017 Dec 1.

3.

Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G.

Ara A, Love RP, Follack TB, Ahmed KA, Adolph MB, Chelico L.

J Virol. 2017 Jan 18;91(3). pii: e02230-16. doi: 10.1128/JVI.02230-16. Print 2017 Feb 1.

4.

Human Cytomegalovirus Tegument Protein pp65 (pUL83) Dampens Type I Interferon Production by Inactivating the DNA Sensor cGAS without Affecting STING.

Biolatti M, Dell'Oste V, Pautasso S, Gugliesi F, von Einem J, Krapp C, Jakobsen MR, Borgogna C, Gariglio M, De Andrea M, Landolfo S.

J Virol. 2018 Feb 26;92(6). pii: e01774-17. doi: 10.1128/JVI.01774-17. Print 2018 Mar 15.

5.

Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets.

Koning FA, Newman EN, Kim EY, Kunstman KJ, Wolinsky SM, Malim MH.

J Virol. 2009 Sep;83(18):9474-85. doi: 10.1128/JVI.01089-09. Epub 2009 Jul 8.

6.

Polymorphisms in the APOBEC3G gene of Chinese rhesus macaques affect resistance to ubiquitination and degradation mediated by HIV-2 Vif.

Jiang ZQ, Yao XR, Yu H, Lu YE, Liu BL, Liu FL, Jin YB, Zhuo M, Zheng YT, Ling F.

Arch Virol. 2019 May;164(5):1353-1360. doi: 10.1007/s00705-019-04194-0. Epub 2019 Mar 11.

PMID:
30859472
7.

Simian Immunodeficiency Virus Vif and Human APOBEC3B Interactions Resemble Those between HIV-1 Vif and Human APOBEC3G.

Wang J, Shaban NM, Land AM, Brown WL, Harris RS.

J Virol. 2018 May 29;92(12). pii: e00447-18. doi: 10.1128/JVI.00447-18. Print 2018 Jun 15.

8.

Activation of nucleotide oligomerization domain 2 (NOD2) by human cytomegalovirus initiates innate immune responses and restricts virus replication.

Kapoor A, Forman M, Arav-Boger R.

PLoS One. 2014 Mar 26;9(3):e92704. doi: 10.1371/journal.pone.0092704. eCollection 2014.

9.

Evasion of adaptive immunity by HIV through the action of host APOBEC3G/F enzymes.

Grant M, Larijani M.

AIDS Res Ther. 2017 Sep 12;14(1):44. doi: 10.1186/s12981-017-0173-8. Review.

10.

APOBEC3 deaminases induce hypermutation in human papillomavirus 16 DNA upon beta interferon stimulation.

Wang Z, Wakae K, Kitamura K, Aoyama S, Liu G, Koura M, Monjurul AM, Kukimoto I, Muramatsu M.

J Virol. 2014 Jan;88(2):1308-17. doi: 10.1128/JVI.03091-13. Epub 2013 Nov 13.

11.

Understanding the regulation of APOBEC3 expression: Current evidence and much to learn.

Covino DA, Gauzzi MC, Fantuzzi L.

J Leukoc Biol. 2018 Mar;103(3):433-444. doi: 10.1002/JLB.2MR0717-310R. Epub 2017 Dec 15. Review.

PMID:
29345375
12.

Heat shock proteins stimulate APOBEC-3-mediated cytidine deamination in the hepatitis B virus.

Chen Z, Eggerman TL, Bocharov AV, Baranova IN, Vishnyakova TG, Kurlander R, Patterson AP.

J Biol Chem. 2017 Aug 11;292(32):13459-13479. doi: 10.1074/jbc.M116.760637. Epub 2017 Jun 21.

13.

Promiscuous RNA binding ensures effective encapsidation of APOBEC3 proteins by HIV-1.

Apolonia L, Schulz R, Curk T, Rocha P, Swanson CM, Schaller T, Ule J, Malim MH.

PLoS Pathog. 2015 Jan 15;11(1):e1004609. doi: 10.1371/journal.ppat.1004609. eCollection 2015 Jan.

14.

Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction.

He Z, Zhang W, Chen G, Xu R, Yu XF.

J Mol Biol. 2008 Sep 12;381(4):1000-11. doi: 10.1016/j.jmb.2008.06.061. Epub 2008 Jun 28.

PMID:
18619467
15.

Replication protein A (RPA) hampers the processive action of APOBEC3G cytosine deaminase on single-stranded DNA.

Lada AG, Waisertreiger IS, Grabow CE, Prakash A, Borgstahl GE, Rogozin IB, Pavlov YI.

PLoS One. 2011;6(9):e24848. doi: 10.1371/journal.pone.0024848. Epub 2011 Sep 15.

16.

HIV restriction by APOBEC3 in humanized mice.

Krisko JF, Martinez-Torres F, Foster JL, Garcia JV.

PLoS Pathog. 2013 Mar;9(3):e1003242. doi: 10.1371/journal.ppat.1003242. Epub 2013 Mar 28.

17.

APOBEC3DE Antagonizes Hepatitis B Virus Restriction Factors APOBEC3F and APOBEC3G.

Bouzidi MS, Caval V, Suspène R, Hallez C, Pineau P, Wain-Hobson S, Vartanian JP.

J Mol Biol. 2016 Aug 28;428(17):3514-28. doi: 10.1016/j.jmb.2016.05.022. Epub 2016 Jun 8.

PMID:
27289067
18.

APOBEC3G and APOBEC3F Act in Concert To Extinguish HIV-1 Replication.

Krisko JF, Begum N, Baker CE, Foster JL, Garcia JV.

J Virol. 2016 Apr 14;90(9):4681-4695. doi: 10.1128/JVI.03275-15. Print 2016 May.

19.

Innate immune signaling induces high levels of TC-specific deaminase activity in primary monocyte-derived cells through expression of APOBEC3A isoforms.

Thielen BK, McNevin JP, McElrath MJ, Hunt BV, Klein KC, Lingappa JR.

J Biol Chem. 2010 Sep 3;285(36):27753-66. doi: 10.1074/jbc.M110.102822. Epub 2010 Jul 8.

20.

Positioning of APOBEC3G/F mutational hotspots in the human immunodeficiency virus genome favors reduced recognition by CD8+ T cells.

Monajemi M, Woodworth CF, Zipperlen K, Gallant M, Grant MD, Larijani M.

PLoS One. 2014 Apr 10;9(4):e93428. doi: 10.1371/journal.pone.0093428. eCollection 2014.

Supplemental Content

Support Center